Kindred Healthcare price target raised to $25 from $20 at Susquehanna Susquehanna raised its price target on Kindred Healthcare following its reaffirmed guidance. The firm noted guidance included its positive perspective on the new LTAC criteria legislation. The company feels it swill be manageable and is unlikely to have a major impact on earnings. Shares are Positive rated.
News For KND From The Last 14 Days
Check below for free stories on KND the last two weeks.